Earnings Feed
Start Free
Home/Filings/4/0000950170-24-073762
4//SEC Filing

Hack Andrew A. F. 4

Accession 0000950170-24-073762

CIK 0001861560other
View on SEC.govCompany Profile

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:53 PM ET

Size

8.9 KB

Accession

0000950170-24-073762

Insider Transaction Report

Form 4
Period: 2024-06-12
Nuvalent, Inc.NUVL
Hack Andrew A. F.
Director
Transactions
  • Award

    Class A Common Stock

    2024-06-12+2,499→ 2,499 total
  • Award

    Stock Option (right to buy)

    2024-06-12+3,789→ 3,789 total
    Exercise: $80.03Exp: 2034-06-12→ Class A Common Stock (3,789 underlying)
Holdings

  • Class A Common Stock

    (indirect: See footnotes)
    2,697,267
Footnotes (4)
  • [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Class A Common Stock. 100% of the RSUs subject to this grant will vest on the earlier of June 12, 2025 or the date of the Issuer's next annual meeting of stockholders, subject to continued service to the Issuer through such vesting date.
  • [F2]The shares underlying this option will vest in full on the earlier of June 12, 2025 or the date of the Issuer's next annual meeting of stockholders, subject to continued service to the Issuer through such vesting date.
  • [F3]Represents shares of Class A Common Stock held directly by Bain Capital Life Sciences Fund II, L.P. ("BCLS Fund II"), BCIP Life Sciences Associates, LP ("BCIPLS") and BCLS II Investco, LP ("BCLS II Investco" and, together with BCLS Fund II and BCIPLS, the "Bain Capital Life Sciences Entities").
  • [F4]Bain Capital Life Sciences Investors, LLC ("BCLSI") is the ultimate general partner of each of BCLS Fund II and BCLS II Investco and governs the investment strategy and decision-making process with respect to investments held by BCIPLS. Dr. Hack is a Partner of BCLSI. By virtue of the relationships described in this footnote, Dr. Hack may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Life Sciences Entities. Dr. Hack disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

Nuvalent, Inc.

CIK 0001861560

→
Entity typeother

Related Parties

1
  • filerCIK 0001657434

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:53 PM ET
Size
8.9 KB
View on SEC.gov